___

• Clayton JA. Applying the new SABV (sex as a biological variable) policy to research and clinical care. Physiol Behav 2018;187:2-5.
• Gendered innovations. Sex and Gender Analysis Policies of Peer-Reviewed Journals. https://genderedinnovations.stanford.edu/sex-and-gender-analysis-policies-peerreviewed-journals.html. Accessed 23 June 2018.
• Heinrich J, Gahart MT, Rowe EJ, Bradley L. Drug safety: most drugs withdrawn in recent years had greater health risks for women. A letter to The Honorable Tom Harkin, The Honorable Olympia J Snowe, The Honorable Barbara A Mikulski, United States Senate, The Honorable Henry Waxman, House of Representatives. Washington, DC: United States General Accounting Office, 2001.
• Heidari S, Babor TF, De Castro P, Tort S, Curno M. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016;1:2.
• European Association of Scientific Editors. Gender Policy Committee. http://www. ease.org.uk/strategy-groups/gender-policy-committee/. Accessed 23 June 2018.
• Gendered innovations. Policy Timeline: Key Governmental, Agency, and Institutional Policies related to Sex and Gender Research. http://genderedinnovations.stanford. edu/policy/timeline.html. Accessed 28 June 2018.
• Bentzen SM, Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 2007;25:4096-103.
• Borgmann K, Dikomey E, Petersen C, Feyer P, Hoeller U. Sex-specific aspects of tumor therapy. Radiat Environ Biophys 2009;48:115-24.